Governance Classic Home
Ajanta Pharma LtdPharmaceuticalsINE031B01049Consolidated₹3316.70-3.00 (-0.09%)
Valuation
Market Cap₹41.44K Cr
TTM PE32.81x
Forward PE31.42x
PEG2.91
Book Value₹388.86
P/B8.53x
TTM EPS₹101.08
Fwd EPS₹105.56
TTM Revenue₹6.22K Cr
TTM PAT₹1.26K Cr
TTM EBITDA₹1.69K Cr
TTM EBIT₹1.51K Cr
Last Qtr PAT₹388.14 Cr
Last Qtr EBITDA₹547.56 Cr
Last Qtr EBIT₹500.00 Cr
Profitability
ROE25.99%
ROCE34.06%
TTM NPM20.31%
TTM EBITDA %27.13%
Curr OPM21.19%
Last OPM19.70%
Curr NPM—
Last NPM—
Curr EPS₹31.07
Last EPS₹26.75
Balance sheet
Equity₹25.07 Cr
Reserve₹4.83K Cr
Total Debt₹134.30 Cr
D/E0.03x
Interest %0.58%
Curr Interest₹2.24 Cr
Price / range
Close₹3316.70
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-0.09%
1W-4.14%
1M-7.38%
3M-5.91%
6M+14.34%
1Y+27.01%
2Y+10.70%
3Y+81.67%
5Y+127.35%
Diwali+12.95%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue1,725.07+41.4%1,488.671,210.531,206.591,220.244,845.92
Other Income52.6270.8262.9825.7675.03204.40
Total Income1,777.69+37.2%1,559.491,273.511,232.351,295.275,050.32
Interest0.790.760.741.870.732.59
Expenditure-1,255.07-28.9%-1,136.04-1,015.90-909.89-973.30-3,819.29
PBDT000000
EBITDA517.09+78.6%396.70239.53340.95289.591,197.99
Depreciation-46.30-43.31-44.16-42.38-41.92-168.77
EBIT470.79+90.1%353.39195.37298.57247.671,029.22
PBT522.62+62.3%423.45257.61322.46321.971,231.03
Tax-142.73-107.98-60.33-77.42-72.44-284.21
Equity25.0725.0725.0725.07025.07
OPM29.4027.1520.2326.1726.3924.38
Net Profit379.89+52.2%315.47197.28245.04249.53946.82
NPM21.3720.2315.4919.8820.4518.75
EPS30.40+52.2%25.2515.7919.6119.9875.79

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue4,845.92+12.1%4,322.04+8.8%3,971.12+16.4%3,411.27+8.6%3,140.64+15.5%2,718.59
Other Income204.40119.87116.48132.75139.73103.57
Total Income5,050.32+13.7%4,441.91+8.7%4,087.60+15.3%3,544.02+8.0%3,280.37+16.2%2,822.16
Expenditure-3,819.29-17.1%-3,261.85-9.1%-2,990.65-5.2%-2,844.17-19.5%-2,379.83-23.9%-1,920.07
Interest-2.59-4.60-6.80-5.23-9.12-6.90
PBDT000000
EBITDA1,197.99-0.6%1,204.72+7.6%1,119.43+60.1%699.28-21.5%890.89-2.8%916.91
Depreciation-168.77-139.93-132.16-126.95-120.96-111.49
EBIT1,029.22-3.3%1,064.79+7.9%987.27+72.5%572.33-25.7%769.93-4.4%805.42
PBT1,231.03+4.3%1,180.06+7.6%1,096.95+56.7%699.85-22.3%900.54-0.2%902.09
Tax-284.21-263.17-289.71-141.13-180.68-226.45
Equity25.0725.070000
OPM (%)24.3826.5727.0020.0027.0032.00
Net Profit946.82+3.3%916.89+13.6%807.24+44.5%558.72-22.4%719.86+6.5%675.64
NPM (%)18.7520.6420.0016.0022.0024.00
EPS (Rs)75.79+3.4%73.28+14.3%64.11+47.0%43.61-47.6%83.28+7.3%77.59
CEPS75.7773.2564.0643.6183.2877.59

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue1,794.16+32.5%1,625.961,421.641,374.841,353.735,452.86
Other Income37.3970.9061.4324.9759.34172.07
Total Income1,831.55+29.6%1,696.861,483.071,399.811,413.075,624.93
Interest2.243.182.365.103.3916.11
Expenditure-1,296.40-20.9%-1,250.06-1,135.96-1,041.21-1,072.26-4,247.28
PBDT000000
EBITDA547.56+67.0%423.58333.41382.24327.831,394.83
Depreciation-47.56-44.50-45.37-43.51-42.97-173.14
EBIT500+75.5%379.08288.04338.73284.861,221.69
PBT535.15+57.0%446.80347.11358.60340.811,377.65
Tax-147.01-112.58-80.41-84.83-80.62-321.65
Equity25.0725.0725.070025.07
OPM29.2226.3323.4025.6224.1224.49
Net Profit388.14+49.2%334.22266.70273.77260.191,056
NPM21.1919.7017.9819.5618.4118.77
EPS31.07+49.2%26.7521.3521.9120.8384.53

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue5,452.86+17.3%4,648.10+10.4%4,208.71+12.5%3,742.64+12.0%3,340.99+15.6%2,889.69
Other Income172.0794.5084.6098.64115.6825.98
Total Income5,624.93+18.6%4,742.60+10.5%4,293.31+11.8%3,841.28+11.1%3,456.67+18.6%2,915.67
Expenditure-4,247.28-19.5%-3,553.44-11.8%-3,179.38-2.7%-3,096.03-21.5%-2,547.19-26.4%-2,015.49
Interest-16.11-20.73-7.21-5.84-10.20-8.27
PBDT000000
EBITDA1,394.83+10.7%1,259.50+7.5%1,171.94+49.6%783.25-15.7%929.30-6.9%998.56
Depreciation-173.14-144.11-135.40-130.80-125.30-116.09
EBIT1,221.69+9.5%1,115.39+7.6%1,036.54+58.9%652.45-18.8%804-8.9%882.47
PBT1,377.65+15.9%1,189.16+6.8%1,113.93+49.5%745.25-18.1%909.48+1.0%900.18
Tax-321.65-268.77-297.76-157.27-196.80-246.31
Equity25.0725.070000
OPM (%)24.4925.0725.9519.4026.3130.87
Net Profit1,056+14.7%920.39+12.8%816.17+38.8%587.98-17.5%712.68+9.0%653.87
NPM (%)18.7719.4119.0115.3120.6222.43
EPS (Rs)84.53+14.9%73.56+13.5%64.82+41.3%45.89-44.3%82.45+9.8%75.09
CEPS84.5173.5364.7745.8982.4575.09

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

22
YearTypeAmountEx-Date
2027Interim Dividend3205 Aug 2026
2026Interim Dividend2810 Nov 2025
2025Interim Dividend2806 Nov 2024
2024Interim Dividend2608 Feb 2024
2024Interim Dividend1004 Aug 2023
Special Dividend1504 Aug 2023
2023Interim Dividend711 Nov 2022
2022Interim Dividend9.509 Nov 2021
2021Interim Dividend9.512 Nov 2020
2020Interim Dividend1315 Nov 2019
2019Interim Dividend909 Nov 2018
2017Interim Dividend723 Mar 2017
2017Interim Dividend607 Nov 2016
2016Interim Dividend817 Mar 2016
2015Final Dividend625 Jun 2015
2014Final Dividend1024 Jul 2014
2013Final Dividend6.2518 Jul 2013
2012Final Dividend7.528 Jun 2012
2011Final Dividend523 Jun 2011
2010Final Dividend3.529 Jun 2010
2009Final Dividend2.530 Jun 2009
2008Final Dividend2.527 Jun 2008

Bonus

2
YearRatioEx-Date
20221:222 Jun 2022
20131:217 Sep 2013

Split

2
YearRatioEx-Date
2015Rs.5/- to Rs.2/-20 Mar 2015
2012Rs.10/- to Rs.5/-09 Aug 2012
Loading company dashboard...
Fetching ratios, charts, and peers